Evidence map›Paper›PMID 23864487›Full record

ArticleCancer causes & control : CCC2013

The California Breast Cancer Survivorship Consortium (CBCSC): prognostic factors associated with racial/ethnic differences in breast cancer survival.

Anna H Wu, Scarlett Lin Gomez, Cheryl Vigen, Marilyn L Kwan, Theresa H M Keegan, Yani Lu, Salma Shariff-Marco, Kristine R Monroe, Allison W Kurian, Iona Cheng and 8 more

Open access · greenAbstract read
In one paragraph

Article in Cancer causes & control : CCC, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 1 synthesis or guideline pooled it, 51 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Immigration and Social Factors, Tumor Stage, and Risk of Contralateral Breast Cancer in Asian American and Hispanic Women.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Neutrophil elastase: From mechanisms to therapeutic potential.Journal of pharmaceutical analysis · 2023
    Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Racial/Ethnic Disparities in Survival after Breast Cancer Diagnosis by Estrogen and Progesterone Receptor Status: A Pooled Analysis.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2021
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 6 institutions in 1 country.

Anna H WuDepartment of Preventive Medicine, Keck School of Medicine, University of Southern California, 1441 Eastlake Avenue, Rm 4443, Los Angeles, CA, 90089, USA, Anna.Wu@med.usc.edu.
Scarlett Lin Gomez
Cheryl Vigen
Marilyn L Kwan
Theresa H M Keegan
Yani Lu
Salma Shariff-Marco
Kristine R Monroe
Allison W Kurian
Iona Cheng
Bette J Caan
Valerie S Lee
Janise M Roh
Jane Sullivan-Halley
Brian E Henderson
Leslie Bernstein
Esther M John
Richard Sposto
Kaiser Permanente · USCancer Prevention Institute of California · USCity of Hope · USStanford University · USUniversity of Southern California · USSouthern California University for Professional Studies · US

Funding

Translational Research Support CoreP30ES007048 · NIEHS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI ROB S MCCONNELL · 1996 to 2026
$46.4M
CALIFORNIA TEACHERS STUDYR01CA077398 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI BERNSTEIN, LESLIE · 1998 to 2014
$29.7M
Multiethnic Cohort Study of Diet and CancerR37CA054281 · NCI · UNIVERSITY OF HAWAII AT MANOA · PI KOLONEL, LAURENCE N. · 2003 to 2012
$23.2M
CALIFORNIA'S PARTICIPATION IN THE NATIONAL CANCER PREVENTION AND CONTRO PROGRAMU58DP000807 · DP · PUBLIC HEALTH INSTITUTE · PI SNIPES, KURT P · 2007 to 2011
$22.5M
Understanding Ethnic Differences in Cancer: The Multiethnic Cohort StudyUM1CA164973 · NCI · UNIVERSITY OF HAWAII AT MANOA · PI HENDERSON, BRIAN E, LE MARCHAND, LOIC · 2012 to 2014
$11.3M
MULTIETHNIC/MINORITY COHORT STUDY OF DIET AND CANCERR01CA054281 · NCI · UNIVERSITY OF HAWAII AT MANOA · PI KOLONEL, LAURENCE N. · 1993 to 2002
$4.5M
Molecular Profiles and Lifestyle Factors in Breast Cancer PrognosisR01CA129059 · NCI · KAISER FOUNDATION RESEARCH INSTITUTE · PI CAAN, BETTE J · 2009 to 2013
$3.6M
VITAMIN D RECEPTOR GENE POLYMORPHISM AND BREAST CANCERR01CA077305 · NCI · NORTHERN CALIFORNIA CANCER CENTER · PI JOHN, ESTHER M · 1999 to 2001
$834k
Research and Mentoring on Energetic Factors and Cancer: Established InvestigatorK05CA136967 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI BERNSTEIN, LESLIE · 2009 to 2013
$684k
BREAST CANCER AND THE BIRTH CONTROL PILL-275933175N01HD033175 · NICHD · UNIVERSITY OF SOUTHERN CALIFORNIA · 1993 to 2003
$298k
BREAST CANCER RISK FACTORS IN HISPANIC WOMENR01CA063446 · NCI · NORTHERN CALIFORNIA CANCER CENTER · PI JOHN, ESTHER M · 1995 to 1998
–
SURVEILLANCE EPIDEMIOLOGY AND END RESULTSN01CN025403 · CN · UNIVERSITY OF SOUTHERN CALIFORNIA · PI ROSS, RONALD K · 1992 to 1996
–
NCCDPHP CDC HHS 1U58 DP000807-01NCCDPHP CDC HHS U58 DP000807NCI NIH HHS HHSN261201000140CNCI NIH HHS K05 CA136967NCI NIH HHS N01 CN025403NCI NIH HHS N01CN25403NCI NIH HHS R01 CA054281NCI NIH HHS R01 CA063446NCI NIH HHS R01 CA077398NCI NIH HHS R01 CA129059NCI NIH HHS R01CA129059NCI NIH HHS R01 CA54281NCI NIH HHS R01 CA77305NCI NIH HHS R01 CA77398NCI NIH HHS R37 CA054281NCI NIH HHS R37CA54281NCI NIH HHS UM1 CA164973NICHD NIH HHS N01-HD-3-3175NIEHS NIH HHS P30 ES007048PHS HHS HHSN26120100034CPHS HHS HHSN26120100035C
6 · The paper itself

Abstract

Racial/ethnic disparities in mortality among US breast cancer patients are well documented. Our knowledge of the contribution of lifestyle factors to disease prognosis is based primarily on non-Latina Whites and is limited for Latina, African American, and Asian American women. To address this knowledge gap, the California Breast Cancer Survivorship Consortium (CBCSC) harmonized and pooled interview information (e.g., demographics, family history of breast cancer, parity, smoking, alcohol consumption) from six California-based breast cancer studies and assembled corresponding cancer registry data (clinical characteristics, mortality), resulting in 12,210 patients (6,501 non-Latina Whites, 2,060 African Americans, 2,032 Latinas, 1,505 Asian Americans, 112 other race/ethnicity) diagnosed with primary invasive breast cancer between 1993 and 2007. In total, 3,047 deaths (1,570 breast cancer specific) were observed with a mean (SD) follow-up of 8.3 (3.5) years. Cox proportional hazards regression models were fit to data to estimate hazards ratios (HRs) and 95 % confidence intervals (CIs) for overall and breast cancer-specific mortality. Compared with non-Latina Whites, the HR of breast cancer-specific mortality was 1.13 (95 % CI 0.97-1.33) for African Americans, 0.84 (95 % CI 0.70-1.00) for Latinas, and 0.60 (95 % CI 0.37-0.97) for Asian Americans after adjustment for age, tumor characteristics, and select lifestyle factors. The CBCSC represents a large and racially/ethnically diverse cohort of breast cancer patients from California. This cohort will enable analyses to jointly consider a variety of clinical, lifestyle, and contextual factors in attempting to explain the long-standing disparities in breast cancer outcomes.

Indexed as

AdolescentAdultAgedAged, 80 and overBreast NeoplasmsCaliforniaEthnicityFemaleHumansLife StyleMiddle AgedPrognosisSurveys and QuestionnairesSurvival RateYoung Adult

Identifiers

PMID23864487
PMCPMC4046898
OpenAlexW2051651175

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.